Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis

Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis

Abstract Background To determine whether initiation of a tumor necrosis factor inhibitor (TNFi) or methotrexate improves hemoglobin A1c in patients with psoriatic arthritis (PsA), rheumatoid arthritis (RA), or ankylosing spondylitis (AS) who also have diabetes mellitus (DM). Methods A retrospective...

Full description

Bibliographic Details
Main Authors: Santhi Mantravadi, Michael George, Colleen Brensinger, Min Du, Joshua F. Baker, Alexis Ogdie
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Rheumatology
Subjects:
Psoriatic arthritis
Rheumatoid arthritis
Ankylosing spondylitis
Diabetes mellitus
Outcomes
Epidemiology
Online Access:http://link.springer.com/article/10.1186/s41927-020-00138-3

Internet

http://link.springer.com/article/10.1186/s41927-020-00138-3

Similar Items